DRTSW

DRTSW

Alpha Tau Medical Ltd. Warrant

$0.245+0.000 (0.000%)

Prix en Temps Réel

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.000

Haut

$0.000

Bas

$0.000

Volume

0.00M

Fondamentaux de l'Entreprise

Statistiques de Trading

Actualités Connexes

GlobeNewswire

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall

Voir plus
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today

Voir plus
Alpha Tau to Participate in May Investor Conferences